Introduction {#s0001}
============

Head and neck (H&N) cancer includes malignant tumours of the lip, oral cavity, nasal cavity and sinuses, pharynx, larynx, salivary glands, and ear. The most common treatment modalities for H&N cancer are external beam radiotherapy and surgery, although an increasing role for chemotherapy can be seen. Radiotherapy and surgery are used either as single-modality therapy or in combination ([@C1]). One important component of clinical care is to consider the patients' quality of life (QoL) in order to be able to identify their different needs during the disease trajectory. The longitudinal pattern of changes in QoL has been reported in a number of studies. From the time of diagnosis to discharge from hospital after surgery, patients with oral cancer showed marked deterioration in physical functioning ([@C2]). In addition, symptoms and problems increased in the domains of swallowing, taste and smell, sticky saliva, body weight loss, and speech. However, at the end of a 12-month follow-up, a significant overall improvement of QoL has been reported ([@C3]). The improvement was especially noted in patients with tumours with lower T stage, whereas patients with a feeding tube had lower and slower improvement in QoL ([@C3]). A follow-up study 5 years after diagnosis of patients with H&N cancer reported improvements in insomnia, pain, global health status, and emotional function, whereas problems with dry mouth, teeth, and sense of smell and taste worsened over time ([@C4]).

Eating-related problems, usually appearing early in the disease and often even before diagnosis, are frequent and reported to have major effects on many patients with H&N cancer ([@C5]). Problems with oral continence, mastication, and swallowing are examples of common dysfunctions often seen after single-modality or combined-modality treatment. In addition, unhealthy habits such as alcohol and tobacco abuse can aggravate body weight loss and nutritional decline ([@C5]). Nutritional surveillance is an important component of clinical care for identifying patients at risk for malnutrition. When required, nutritional treatment often initially involves food enrichment and oral supplements. If the patient cannot swallow but has a functioning gastrointestinal tract, enteral tube feeding is preferred ([@C5],[@C12]). The two most common methods for enteral feeding are the polyurethane nasogastric feeding tube (NGT) and the percutaneous endoscopic gastrostomy (PEG) tube. Risks and benefits are associated with both methods. NGT is mainly used on a short-term basis ([@C8]). Examples of NGT complications include pharyngeal ulceration, altered body image, tube blockages, and tube dislodgements ([@C8]). PEG is used on a short- and long-term basis and is preferred because of the assumption that it provides higher subjective and social acceptance ([@C13]). Complications that can arise from PEG use are pain (especially in the first days/weeks), leakage, wound infections, bleeding, gastric/esophageal perforation, pneumoperitoneum, and peritonitis ([@C5]). Early PEG insertions (before or within 1 month of treatment) have shown a smaller decrease in patients' body mass index (BMI) at 12 months compared with receiving PEG after 1 month or more of treatment ([@C16]). Corry et al. ([@C17]) compared NGT and PEG in a group of patients with H&N cancer and found no differences regarding general physical condition and overall QoL. Patients with PEG lost less body weight 6 weeks after treatment, but 6 months after treatment there were no differences in body weight loss ([@C17]). However, patients with NGT had significantly more complications related to tube dislodgements, and patients with PEG had significantly more infections. Moreover, the costs for PEG were higher than for NGT ([@C17]). Today there is an ongoing clinical and academic debate about when enteral nutrition should be initiated and which enteral nutrition method to use, NGT or PEG. In this debate, the patients' experiences of having NGT or PEG, and the positive or negative aspects, are seldom included.

The concept of QoL pertains to general well-being and is multidimensional, including physical, psychological/emotional, and social functioning, disease- and treatment-related symptoms, and perceived health status ([@C18]). The definition 'health-related QoL' (HRQoL) is sometimes preferred, as it is not as broad and focuses on health status and disease-related issues, such as symptoms and functions ([@C19],[@C20]). Instruments measuring QoL issues are mainly generic or condition/disease-specific ([@C18]), although several instruments combine generic with condition/disease-specific issues. Well-known questionnaires used in studies of QoL and HRQoL in patients with H&N cancer include The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30) ([@C21]), with the H&N cancer-specific module (EORTC QLQ-H&N35) ([@C22]), and The University of Washington Quality of Life Scale (UW-QoL) version 4 ([@C23],[@C24]). Standardized questionnaires focus on predefined problems and may therefore overlook many QoL aspects important on an individual level ([@C18],[@C25]). Consequently, these questionnaires may fail to consider the individual's own perspective of what is negatively (or positively) affected by the disease. The Schedule for the Evaluation of Individual Quality of Life--Direct Weighting (SEIQoL-DW) is an individual-based instrument without predefined items, thus allowing identification of both negative and positive values in life ([@C26],[@C27]). There is a body of knowledge showing that patients with H&N cancer experience emotional and physical distress during treatment and that problems related to nutritional state are prominent. However, there is less knowledge about how relevant these problems are on an individual level, whether there are any positive consequences following the disease, and if enteral nutrition influences patients' daily lives.

The aim of this study was to explore individual quality of life in a sample of patients with head and neck cancer from the time of diagnosis up to 3 months after termination of radiotherapy with the specific research questions: 1) Which areas in life are important to quality of life, and which are influenced by the disease and by having oral or enteral nutrition; and 2) Which areas in life are influenced by having a nasogastric feeding tube (NGT) or a percutaneous endoscopic gastrostomy (PEG) tube?

Material and methods {#s0002}
====================

Patients were interviewed at three time points: the start of radiotherapy (T1), 2 weeks after termination of radiotherapy (T2), and 3 months after termination of radiotherapy (T3).

Setting and sample {#s0003}
------------------

Over a period of 6 months, 73 patients at a university hospital in Sweden were consecutively allocated at a weekly multi-disciplinary team conference where treatment modality was decided. Patients were included if they were planned to receive radiotherapy (duration 6--7 weeks) with a curative intention either as a single-modality treatment or in combination with other treatment modalities. Exclusion criteria were inability to participate in the interviews (i.e. being unable to speak fluent Swedish, having dementia, or having psychiatric disorders). Based on these criteria, 9 were excluded, leaving 64 eligible patients. Twenty-three declined participation, leaving 41 patients enrolled, of whom 36 completed the whole study. The 5 patients who did not take part in all the interviews either declined further participation (*n* = 3), or died during the study (*n* = 2). The number of participants at the three interview occasions was 41, 38, and 36 at study times T1, T2, and T3, respectively. The patients were divided into two groups at T2 and T3, depending on whether they maintained oral feeding (OF group) or needed enteral nutrition (EN group). Patients were given enteral nutrition if they lost \>5% of their initial body weight, or if they had a stage IV tumour and swallowing problems ([@C14]). The choice of NGT or PEG was mainly based on the clinical and traditional decision by the physician.

Data collection {#s0004}
---------------

The Schedule for the Evaluation of Individual Quality of Life--Direct Weighting (SEIQoL-DW) is an interview-based questionnaire developed to describe individual QoL without using predefined variables ([@C26],[@C27]). The original SEIQoL included only a generic part (henceforth SEIQoL-G), but in the Swedish modified and extended version a disease-related (SEIQoL-DR) part was added ([@C28]). The generic part generates areas that patients describe as important for their general QoL, and the disease-related part generates aspect that the patients describe to be specifically affected by the disease. The extended disease-related part has been previously shown to be feasible and valid when used in patients with cancer ([@C29]). For the purpose of the present study, a third part was developed and added to capture patients' descriptions of perceptions and problems related to enteral nutrition (SEIQoL-EN).

The interviews included all three parts at the same time for each patient. Firstly, the patients were asked the question according to the SEIQoL-G, 'If you think about your life as a whole, what are the most important things, both good and bad, in your life at present that are crucial for your QoL?' Secondly, they were asked the question according to the SEIQoL-DR part, 'If you think about the fact that you will be/are being/have been treated for cancer, what things in your life are influenced, both positively and negatively, by the disease?' Finally, the patients that had any type of feeding tube were asked the question according to the SEIQoL-EN part, 'If you think about the feeding tube (NGT or PEG), what things in your life are influenced, both positively and negatively, by this experience?' In all three parts of the interview the respondents could freely identify as many areas as they wanted.

Demographic data (sex, age, marital status, and educational level) were collected at the first interview. Clinical data (diagnosis, TNM classification, stage, and treatment) were collected from the patients' medical records.

Procedure {#s0005}
---------

All patients were given oral and written information about the study, and those who agreed to participate gave their written informed consent. In total, 115 interviews were performed mainly at the hospital (81%), while some interviews at T2 and T3 (19%) were performed by telephone due to prohibitively long distances to the hospital. Interviews ranged from 10 to 60 minutes (mean = 26 minutes). Three persons trained to use the instrument conducted the interviews: two of the authors, and a registered nurse at the clinic.

Analyses {#s0006}
--------

The interviewer took verbatim notes of patient answers in accordance with the interview protocol, i.e. different notes were made under each of the three different parts. To make sure that their intentions and feelings were fully described, the patients were asked to verify their statements. The notes were then transcribed into three consolidated texts for SEIQoL-G, SEIQoL-DR, and SEIQoL-EN, respectively. These three text transcriptions were analysed separately from each other. All three transcriptions were analysed according to Elo and Kyngäs ([@C30]), using inductive qualitative content analysis. Content analysis is a method that can be used to draw valid conclusions about a manifest message in a communication by systematic identification of specified communication characteristics. Data from the open-ended questionnaires are suitable for this technique. The analysis was first performed with the text from the SEIQoL-G followed by SEIQoL-DR and finally SEIQoL-EN. The transcriptions were read through several times, and subsequently words and sentences that shared the same meaning from the transcripts were coded. The codes were then transferred to a coding sheet, one for each part, where similar codes were grouped together; by comparing differences and similarities, main categories and sub-categories were created. Codes that were worded in a positive sense were grouped together within each category. The first author carried out this first step of the analysis. Thereafter, two of the other authors read the material and compared the main categories and sub-categories within each part with the codes by defining their boundaries. In repeated meetings, the research group discussed and modified the categories within each part until consensus was achieved. Appropriate quotations are used in the results to illustrate the categories. Frequencies and per cent with which each category is mentioned by patients are presented ([@C31]). To assess differences in the proportion of the categories and number of patients, regarding all three parts, Fisher's exact test was calculated.

Ethical approval {#s0007}
----------------

The Regional Ethical Review Board in Stockholm, Sweden, reviewed and approved the study (entry no: 04-456/3).

Results {#s0008}
=======

Descriptive data {#s0009}
----------------

Demographic and clinical characteristics of the 41 participating patients with H&N cancer are presented in [Table I](#TB1){ref-type="table"}. Table I.Demographic and clinical characteristics of patients with head and neck cancer (*n* = 41).CharacteristicNumber of patients (%)Sex Male28 (68) Female13 (32)Age Mean age, years62.3 30--39 years1 (3) 40--49 years3 (7) 50--59 years10 (24) 60--69 years18 (44) 70--79 years7 (17) 80--89 years2 (5)Marital status Married, cohabiting31 (76) Single, divorced, or widowed10 (24)Educational status (highest level) Mandatory13 (32) High school/college12 (29) University13 (32) Other3 (7)Diagnosis Oropharynx15 (37) Oral cavity8 (20) Larynx5 (12) Unknown primary4 (10) Nasopharynx3 (7) Salivary glands3 (7) Hypopharynx2 (5) Oral cavity and oropharynx1 (2)Tumour stage (I--IV) I6 (14) II5 (12) III4 (10) IV22 (54) No stage4 (10)Treatment Radiotherapy16 (39) Radiotherapy and surgery9 (22) Surgery and radiotherapy3 (7) Combination treatment^a^13 (32)[^1]

In total, 18 patients (44%) maintained oral feeding (OF group, *n* = 18) during the entire study period, and 23 patients (56%) received enteral nutrition (EN group, *n* = 23), of whom 14 were given PEG, and 9 NGT.

Areas of general QoL and relation to enteral nutrition {#s0010}
------------------------------------------------------

The patients' descriptions of important areas of general QoL were wide-ranging but consistent from the time of diagnosis and up to 3 months after the termination of radiotherapy, and could be organized in 13 general categories ([Table II](#TB2){ref-type="table"}). In the interviews patients described the family to be of most importance. Those who had a partner said that he/she was the most important person in their lives, and this was also the person they turned to for support. The patients who had children and grandchildren described that they were a joy and of great importance for them. Other important areas brought up by the patients were related to their own health, of wanting to be healthy and wishes to be like other people including, for example, people with normal physical appearance, not suffering from pain, being able to eat and drink orally, and also to be able to eat and drink together with other people. The patients also described how they in different ways liked to perform different leisure activities like being outdoors in nature, walking, exercising, and reading. There were no differences in frequencies of the different categories between the patients in the OF and EN groups, except for housing/living conditions at T3 (*p* \< 0.01). Thus, patients in the OF group described housing/living conditions more often. Table II.Categories of most important areas in life (SEIQoL-G) found from interviews of patients with head and neck cancer over time: at start of radiotherapy (T1), 2 weeks (T2) and 3 months (T3) after the termination of radiotherapy, divided into two groups--oral feeding (OF) and enteral nutrition (EN). Numbers and percentages show frequencies of nominations in each category.T1^a^T2^b^T3^b^Main categories*n* (%)OF *n* (%)EN *n* (%)OF *n* (%)EN *n* (%)Total number of participants4117211818Family/relation to family35 (85)10 (5916 (76)11 (61)15 (83)Own health18 (44)9 (53)11 (52)8 (44)14 (78)Interest/leisure activities30 (73)7 (41)5 (24)7 (39)6 (33)Friends/relations to other people19 (46)6 (35)8 (38)6 (33)6 (33)Work18 (44)6 (35)4 (19)5 (28)6 (33)Housing/living conditions17 (41)3 (18)1 (5)9 (50)^c^3 (17)^c^Psychological impact3 (7)2 (12)4 (19)1 (6)4 (22)Finances6 (15)1 (6)0 (0)2 (11)0 (0)Pets3 (7)1 (6)1 (5)2 (11)1 (6)Health of someone close2 (5)1 (6)0 (0)2 (11)0 (0)Environment1 (2)0 (0)1 (5)0 (0)0 (0)Society/politics1 (2)1 (6)0 (0)0 (0)0 (0)Religion/spirituality1 (2)0 (0)0 (0)0 (0)0 (0)[^2]

Areas of disease-specific QoL and relation to enteral nutrition {#s0011}
---------------------------------------------------------------

Negative impacts on physical, psychological, existential, and social problems were described by the patients related to the disease, but also positive experiences emerged from the interviews ([Table III](#TB3){ref-type="table"}). The most common physical health problems concerned fatigue, pain, and eating problems. Psychological issues were described in the interviews by the patients as a worrying feeling and some patients also felt depressed. In addition, the patients also described existential problems: they had thoughts and worries about their disease, and some patients' thoughts occupied and affected them a lot and were time-consuming as they could not stop thinking about their disease and what would happen in the future. Positive aspects were also described by the patients, mostly of a social character, about family and friends and the relationship to them. How family and friends were there for them, helped them, visited, or telephoned them. Some patients also described how they themselves tried to make the best of their life situation. There were no differences in the number of statements made with regard to areas influenced by disease between the OF and EN groups at T2 and T3 ([Table IV](#TB4){ref-type="table"}). Table III.Examples of quotes describing the different categories influenced by the disease (SEIQoL-DR) as reported by patients with head and neck cancer (*n* = 41).Main categoriesSub-categories*n*Examples of quotes*Negative aspects*Health aspects:SymptomsFatigue/loss of energy24I'm not recovering in the way I expected. I'm getting impatient. It affects my daily life--cleaning the house, and so on, is difficult. I'm tired both psychologically and physiologically. I get tired when I'm walking.Pain20It hurts inside my mouth and throat, and the skin on my neck also hurts.Xerostomia14My mouth is very dry because of the radiotherapy.Skin/mucous impairment10I'm sore in my mouth as I've got blisters, and the skin on my neck is red and itchy.Viscous phlegm6I have problems with stiff, viscous phlegm.Loss of hair3I have hair loss around my ears after the radiotherapy treatment.Function restrictionsPsychological impact18I'm psychologically affected and I feel worried. I feel slightly depressed sometimes.Sleeping problems11I have sleeping problems and I wake up many times during the night. It's hard to fall asleep again.Speaking problems6I'm wheezing, have hoarseness, my voice is affected, and mainly in the morning I've got lots of viscous phlegm.Hearing problems4After treatment, my hearing capacity is reduced in my right ear.Tooth extraction4It's been horrible to take out good teeth before treatment.Altered body appearance3My face looks different and I feel strange.Impact on sexual life2I don't have a normal sex life.NutritionEating problems/ dysphagia20I've got problems with chewing and swallowing food.Eating habits/taste changes14I have no taste. I'm eating normal food again but feel it is boring when there is no taste, except for sometimes the first bite having taste.Loss of appetite9I have problems with my appetite.Enteral nutrition5I'm bored with enteral food. I really wish I could eat normal food.Losing weight5I haven't been able to eat, and have lost between 10 and 12 kg. I'm pleased with my weight reduction.Social restrictionsSocial life14Restrictions in my social life, especially in contacts with other people and friends.Family life13I'm worried about my family--what they think about the situation.Work/financial13My economy is affected because of the cancer. The money I get when I am sick doesn't cover our expenses, I have to take from our savings and it affects the whole family. We can't do fun things with the children that are costly.Thoughts about disease22My whole life is affected by the cancer. I'm thinking about it all the time, even though I'm trying not to.Treatment-related concerns17The disease changes your entire life. My life is now about treatment, the intake of calories, and killing time in between. It's a full-time job.Opinions on health care9The rehabilitation has taken much longer than what they said it would take, and I am surprised over the fact of having 12 meetings with 9 doctors during my radiotherapy treatment. Insufficient information about side-effects and that everything takes such a long time. Also, the appointments with different doctors each time is so frustrating.*Positive aspects*Social improvementsFamily life8My wife and daughter are very engaged in my situation.Social life8People--friends and relatives have been in contact with me. They care.View of life and oneself11I'm living in the present and trying to enjoy life (e.g. the spring, flowers, and grandchildren).Thoughts about disease and treatment11I'm very happy and at ease now since I've talked to the doctor who told me the cancer is cured.Opinions on health care9A good continuity of the nurses. Both the staff and doctors have been answering my questions.Miscellaneous5Smoking is both positive and negative. I don't want to quit. Table IV.Categories of areas influenced by the disease (SEIQoL-DR) found from interviews of patients with head and neck cancer over time: at start of radiotherapy (T1), 2 weeks (T2) and 3 months (T3) after the termination of radiotherapy, divided into two groups--oral feeding (OF) and enteral nutrition (EN). Numbers and percentages show frequencies of nominations in each category.T1^a^T2^b^T3^b^Main categories*n* (%)OF *n* (%)EN *n* (%)OF *n* (%)EN *n* (%)Total number of participants4117211818*Negative aspects*Health aspects30 (73)15 (88)17 (81)14 (78)16 (89)Social restrictions19 (46)5 (29)4 (19)4 (22)5 (28)Thoughts about disease15 (37)6 (35)4 (19)6 (33)3 (17)Treatment-related concerns9 (22)5 (29)4 (17)1 (6)0 (0)Opinions on health care0 (0)2 (12)2 (10)3 (17)2 (11)*Positive aspects*Social improvements10 (24)0 (0)2 (10)2 (11)1 (6)View of life and oneself5 (12)0 (0)4 (19)3 (17)1 (6)Thoughts about disease and treatment1 (2)2 (12)3 (14)4 (22)2 (11)Opinions on health care2 (5)1 (6)2 (10)3 (17)1 (6)Miscellaneous2 (5)0 (0)1 (5)2 (11)0 (0)[^3]

Areas in life related to having NGT or PEG {#s0012}
------------------------------------------

The patients with NGT (*n* = 9) or PEG (*n* = 14) described in the interviews both positive and negative feelings about having a feeding tube ([Table V](#TB5){ref-type="table"}). Many of the patients expressed in the interviews positive aspects about receiving enteral nutrition. They did not have to battle with each meal and to worry about not getting beverage and food, they received calories, and realized they would have lost body weight without it. The negative aspects described in the interviews by the patients concerned problems with the feeding procedure as it was time-consuming and for some patients it was difficult to manage to take all the planned nutritional bags per day. They also described practical difficulties with handling the tube and in connection to the feeding procedure. Other negative problems described by the patients were about having the tube (NGT or PEG), how it was irritating to have the NGT in the nose and throat, and that the stomach area around the PEG tube hurt. They felt unhygienic, for example, as the tube was disturbing when they tried to sleep, and they felt embarrassed being around other people. Some patients also described that they missed eating and drinking orally. The categories found from the interviews are presented with quotes from the interviews ([Table V](#TB5){ref-type="table"}). The greatest variations of number of statements were noticed in the categories 'Confined to a tube' and 'Social limitations'. In comparison with patients with NGT, patients with PEG more often stated that the manner of insertion of the PEG tube was a negative experience, yet stated less often that it was embarrassing. Table V.Category descriptions and examples of quotes found from interviews (SEIQoL-EN) of patients with head and neck cancer receiving enteral nutrition by either the polyurethane nasogastric feeding tube (NGT) or the percutaneous endoscopic gastrostomy (PEG) tube. Numbers and percentages show frequencies of nominations in each category.Number of patients (%)Main categoriesSub-categoriesExamples of codesNGT (*n* = 9)PEG (*n* = 14)*p* value^a^NutritionNutritional comfortIt is positive. I do not have to panic about meals. I get nutrition without having to worry about not being able to swallow6 (67)13 (93)0.26Maintaining and gaining weightPositive as I realize that I would have lost weight without it4 (44)5 (36)1.00Long feeding timeIt takes lots of time. To take all three bags in one day is hard to manage3 (30)6 (43)1.00Missing oral eatingI cannot eat. I miss eating orally. It is hard. I cannot chew3 (30)4 (29)1.00Losing weightIt is hard to maintain my weight0 (0)2 (14)0.50FunctionFunctioning wellI have learned to live with tube feeding5 (56)9 (64)1.00Difficult to handlePractically, it is difficult to handle the tube, the syringe, and tube feeding2 (22)4 (29)1.00Gastrointestinal problemsI easily feel nauseous in connection to tube feeding4 (44)2 (14)0.16Nose and throat problemsMy nose feels irritated by the NGT2 (22)1 (7)0.54PainIt hurts around the PEG tube0 (0)5 (36)0.12LimitationsFeel unhygienicI feel unhygienic--it smells bad1 (11)6 (43)0.18Confined to a tubeIt is negative because the tube is in the way. The tube disturbs my sleep. I feel confined to the tube when feeding1 (11)8 (57)\<0.05Social limitationsI feel embarrassed to have the NGT in my nose6 (67)1 (7)\<0.01MiscellaneousI only use the PEG in the mornings, so I am hoping to get rid of it soon0 (0)4 (29)0.13[^4]

Discussion {#s0013}
==========

The areas nominated by the patients as important to their general QoL were close to the findings from other studies in patients diagnosed with cancer ([@C32],[@C33]). In these and the present study, the areas of importance were also similar to what the general population proclaim are important in life ([@C28]).

Overall, our results confirm that eating is a fundamental aspect of life that is often affected by the disease and treatment in patients with H&N cancer. More than half of the areas that the patients mentioned as influenced by the disease had some connection with nutritional problems. Eating problems, such as difficulty in chewing or opening the mouth, loss of taste, and experience of pain, for example, may affect patients in many ways, leading to prolonged eating time, reduced eating pleasure, and not being able to eat with family and friends. However, except for statements on housing and living there seemed to be no differences related to all aspects affected by general QoL and disease in patients with oral eating versus enteral nutrition. This finding is in contrast to that of Ringash et al. ([@C3]), who found that patients with H&N cancer receiving enteral nutrition had significantly less improvement in physical and functional well-being 6 months after treatment compared to patients that did not need enteral nutrition. However, prolonged use of enteral nutrition may be related to having a more advanced stage of disease, which could explain the decline in QoL ([@C9]).

A typical experience for patients having PEG was that the tube was disturbing and uncomfortable, causing sleeping problems and forcing them to stay at home. Typical for patients with NGT was that they felt embarrassed because part of the tube is visible, which in turn hindered social activities. Patients with NGT talked more about irritation in the nose and throat, drooling, viscous phlegm, and feelings of nausea when eating than did patients with PEG. Similar problems, such as pharyngeal ulceration, inconvenience in using NGT, and altered body image, interference in family and social life, were described by Corry et al. ([@C17]) when they compared NGT with PEG in a group of patients with H&N cancer. Furthermore, they did not find any differences in overall QoL between the two methods 1 week after enteral nutrition insertion or 6 weeks after completion of treatment. At this time point, many patients treated with radiotherapy are still experiencing treatment side-effects that affect swallowing. In another study on patients with H&N cancer, significant differences were noted regarding QoL in favour of PEG at 6 weeks post-insertion as well as for weight ([@C34]). In our study, patients with PEG more frequently reported problems with the unhygienic feeling of the PEG tube with regard to leakage and a bad odour, for example, as well as pain around the stoma compared to patients with NGT. Stomach pain is a known complication in connection with and after PEG insertion ([@C14],[@C17]). The problem of leakage has previously been addressed as a disturbing complication associated with the PEG procedure ([@C5],[@C14],[@C15]).

The version of the SEIQoL instrument used in this study proved to be a good method to capture areas in life that are affected by disease and treatment in patients with H&N cancer. It allowed the patients to express their present life situation in their own words. When comparing the statements from the interviews, several areas emerged that are not included in frequently used instruments (e.g. the EORTC QLQ-C30, EORTC-H&N35, and UW-QoL) in this patient group. The patients in our study gave their opinions on health care and mentioned their concerns about treatment. Questions regarding these matters are not included in these questionnaires. Most importantly, the patients in our study often referred to nutrition-related problems influencing their life situation, but only a few questions on nutritional problems are included in the EORTC questionnaires, and none in the UW-QoL. Finally, the patients noted some positive areas not captured in the standardized questionnaires. Applying the SEIQoL questionnaire is rather time-consuming, as it is generally used in face-to-face interviews. In this case, 19% of the interviews were conducted by telephone due to long distances. For the future, telephone interviews alone might be a good option ([@C35],[@C36]). Although shorter and self-reported questionnaires save time, they might miss areas of importance to individual patients. One way to solve this dilemma is to add open-ended questions to standardized questionnaires, which would allow patients to report personal concerns.

Limitations in our study were the rather small sample size, and that the patients did not have homogeneous types of H&N cancer, or the same treatment modalities; all patients received radiotherapy, but some also receiving surgery, chemotherapy, or brachytherapy, which could have influenced the results. However, in a long-term follow-up study (25 months), different treatment modalities for advanced oropharynx cancer did not affect specific problem areas ([@C37]). In this study and especially when comparing patients with NGT and PEG, the sample size is too small for generalizations; it only provides indications. A larger study is needed to confirm the result concerning the comparison between NGT and PEG.

In conclusion, eating aspects are fundamental in life for patients with head and neck cancer, but the perception of general or disease-related quality of life did not differ between patients receiving enteral nutrition and patients who did not. Patients receiving enteral nutrition regarded that type of treatment as something positive and necessary. However, both NGT and PEG were associated with restrictions with different spectra. From the patients' perspective neither of the two feeding tubes was clearly in favour. We suggest that more studies are needed on how the choice of enteral feeding tube can be evidence-based, and incorporating the patients' perspective.
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[^1]: ^a^Radiotherapy and chemotherapy, and/or brachytherapy, and sometimes surgery.

[^2]: ^a^At T1, 4/41 had EN.

    ^b^There were no differences between the OF and EN groups (Fisher's exact test).

    ^c^Except for statements regarding housing/living conditions where a statistically significant difference was seen at T3 (Fisher's exact test).

[^3]: ^a^At T1, 4/41 had EN.

    ^b^There were no statistically significant differences between the OF and EN groups (Fisher's exact test).

[^4]: ^a^Fisher's exact test.
